Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 969 of 5804
-
New drug cocktail aims to shrink NF1 tumors
Disease control Not yet recruitingBased on the clinical activity of both selumetinib and cabozantinib as monotherapies in clinical trials, the demonstrated activity of these agents in reduced doses in preclinical studies, and the non-overlapping toxicity profiles, the study will assess the tolerability and effica…
Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Magic Mushroom-Like drug tested for depression and anxiety
Knowledge-focused Recruiting nowThe goal of this study is to learn how psychedelics may help symptoms of depression and anxiety. Participants with major depressive disorder experiencing symptoms of depression and anxiety will receive one dose of either a drug related to psilocybin or a placebo. Assessments incl…
Phase: PHASE2 • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New study aims to boost PrEP use among black men who have sex with men
Prevention Not yet recruitingThe goal of this clinical trial is to learn if two interventions-C4 and C4+3MV-can improve PrEP adherence (taking medication to prevent HIV) among Black men who have sex with men (MSM). The study will also explore the most effective ways to support participants in continuing thei…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
New app aims to tame anger in veterans with brain injury and PTSD
Symptom relief Not yet recruitingThis randomized clinical trial will enroll 100 Veteran-family/friend dyads to test the efficacy of CALM in treating anger in TBI and PTSD. The investigators hypothesize that compared to an active control group, Veterans randomized to the CALM group will demonstrate: * Significan…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Gene test picks patients for targeted immunotherapy trial
Disease control Not yet recruitingThis is a Phase 2, single-arm, multicenter study, evaluating the anti-tumor efficacy of tumor-infiltrating lymphocyte (TIL) directed tislelizumab monotherapy (also known as BGB-A317) for refractory solid tumors in approximately 72 patients with centrally confirmed T cell inflamed…
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for Cushing's patients with high blood pressure
Disease control Not yet recruitingOsilodrostat has proven to be a safe and efficacious treatment for patients with CS. Demonstrating normalisation of hypercortisolaemia and in patients with hypertension and/or dysglycaemia clinically relevant and statistically significant reductions in blood pressure and glycaemi…
Phase: PHASE4 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a pill and brain zaps help you quit smoking for good?
Disease control Recruiting nowThe goal of this clinical trial is to learn if a combination of varenicline and enhanced accelerated Transcranial Magnetic Stimulation (aTMS) works to help adults quit using nicotine products. Researchers will compare varenicline + active aTMS with a single dose of D-Clycloserine…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could shorter hormone therapy be just as effective for prostate cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to study definitive external beam radiation therapy together with drugs called androgen deprivation therapy (ADT) in patients with prostate cancer. The investigators want to find out if these drugs work the same way if they are given for 6 month…
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug cocktail aims to soothe ICU delirium and prevent breathing tubes
Symptom relief Not yet recruitingThis investigator-initiated, randomized, controlled, single-blind, superiority trial aims to assess the efficacy and safety of esketamine combined with dexmedetomidine for the management of agitation or delirium in intensive care unit (ICU) patients receiving non-invasive respira…
Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Can MRI scans spare rectal cancer patients from unnecessary surgery?
Knowledge-focused Not yet recruitingRectal cancer presents a significant global health challenge. Despite improvements in clinical outcomes, significant disparities persist across Europe. These differences are explained not only by the heterogeneity of risk factors and screening strategies, but also by variations i…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial
Disease control Not yet recruitingPhase I dose escalation study of 211At-MABG in adults with advanced pheochromocytoma / paraganglioma (PPGL) or other NET-overexpressing cancers (as evidenced by positive MIBG imaging) who are refractory to, lacking, or ineligible for approved treatments. Phase 1 dose-escalation w…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to predict which surgery patients are at highest risk in poorer nations
Knowledge-focused Not yet recruitingThe primary objective of this study is to develop and validate a multivariable risk prediction model for 30-day major postoperative complications and mortality in patients undergoing major surgery across participating international centers. Despite advancements in perioperative c…
Sponsor: Hospital Departamental de Villavicencio • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could a drug tame excess cortisol in a common hormone disorder?
Disease control Not yet recruitingsingle-center, randomized, double-blind, placebo-controlled Phase 2 study to evaluate safety and efficacy of overnight metyrapone in patients with MACS.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Massive heart study aims to sharpen diagnosis and cut needless hospital stays
Knowledge-focused Not yet recruitingSuspected acute or subacute cardiovascular diseases-including chest pain, dyspnea, and palpitations-are among the most common reasons for unscheduled emergency department visits and pre-hospital referrals. Despite this high clinical burden, the diagnostic yield is often limited, …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Ultrasound-Guided fluid therapy may cut lung risks in elderly cancer surgery
Disease control Not yet recruitingBrief Summary This clinical trial aims to evaluate whether perioperative goal-directed fluid therapy (GDFT) targeting a venous excess ultrasound (VExUS) score of 1 can reduce postoperative pulmonary complications (PPCs) in elderly patients undergoing McKeown minimally invasive es…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Chemotherapy drug temozolomide under review for tough pituitary tumors
Disease control Not yet recruitingTemozolomide is the main chemotherapy drug used for aggressive pituitary tumors and pituitary carcinomas that do not respond to standard treatments like surgery or radiation. Most of what is known about how well this treatment works comes from small studies in Europe and the Unit…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could Urine-Derived exosomes or ozone therapy restore erections after prostate cancer surgery?
Disease control Not yet recruitingThis prospective, randomized, controlled trial aims to evaluate and compare the therapeutic efficacy of intracavernosal urine-derived exosomes and systemic rectal ozone therapy in patients experiencing erectile dysfunction (ED) post-robotic-assisted radical prostatectomy (RARP). …
Phase: NA • Sponsor: Medipol University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could removing lead protect kidneys in diabetes?
Disease control Not yet recruitingThis is a single-arm prospective clinical study conducted at The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Previous basic research has found that patients with type 2 diabetic nephropathy have higher blood lead levels than ordinary people, and lead acc…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Steam power: can a quick vapor treatment ease prostate symptoms for years?
Disease control Recruiting nowRezūm is a minimally invasive procedure that uses water vapor (steam) to treat urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia, BPH). It has been used in clinical practice since receiving FDA approval in 2015 and is recommended as a treatment option …
Phase: NA • Sponsor: Sechenov University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Digital peer support may ease long-term stroke recovery for younger survivors
Symptom relief Not yet recruitingStroke survivors often experience persistent unmet needs during long-term recovery. Young and middle-aged stroke survivors may face additional challenges in balancing rehabilitation with work and family responsibilities. Although digital health interventions have the potential to…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC